nodes	percent_of_prediction	percent_of_DWPC	metapath
Methadone—ABCB1—adrenal gland cancer	0.963	1	CbGaD
Methadone—Loperamide—POMC—adrenal gland cancer	0.00442	0.432	CrCbGaD
Methadone—Oxaprozin—PTGS2—adrenal gland cancer	0.00127	0.124	CrCbGaD
Methadone—Phenylbutazone—PTGS2—adrenal gland cancer	0.00084	0.0821	CrCbGaD
Methadone—Fexofenadine—ABCB1—adrenal gland cancer	0.000828	0.0809	CrCbGaD
Methadone—Clotrimazole—ABCB1—adrenal gland cancer	0.00064	0.0626	CrCbGaD
Methadone—Fentanyl—ABCB1—adrenal gland cancer	0.000547	0.0535	CrCbGaD
Methadone—Loperamide—ABCB1—adrenal gland cancer	0.000527	0.0515	CrCbGaD
Methadone—Trimipramine—ABCB1—adrenal gland cancer	0.000396	0.0387	CrCbGaD
Methadone—Promethazine—ABCB1—adrenal gland cancer	0.000381	0.0372	CrCbGaD
Methadone—Tamoxifen—ABCB1—adrenal gland cancer	0.000378	0.037	CrCbGaD
Methadone—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	6.91e-05	0.00257	CbGpPWpGaD
Methadone—CYP3A7—Biological oxidations—POMC—adrenal gland cancer	6.83e-05	0.00254	CbGpPWpGaD
Methadone—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—adrenal gland cancer	6.81e-05	0.00254	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—SH3KBP1—adrenal gland cancer	6.81e-05	0.00253	CbGpPWpGaD
Methadone—OPRD1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	6.64e-05	0.00247	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—TSHR—adrenal gland cancer	6.62e-05	0.00246	CbGpPWpGaD
Methadone—CYP2D6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	6.61e-05	0.00246	CbGpPWpGaD
Methadone—OPRK1—GPCR ligand binding—GNAS—adrenal gland cancer	6.58e-05	0.00245	CbGpPWpGaD
Methadone—CYP2C9—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	6.55e-05	0.00244	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—GNRH1—adrenal gland cancer	6.51e-05	0.00242	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—GNRHR—adrenal gland cancer	6.42e-05	0.00239	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—ZNRF3—adrenal gland cancer	6.4e-05	0.00238	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—TSHR—adrenal gland cancer	6.39e-05	0.00238	CbGpPWpGaD
Methadone—CYP1A2—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	6.37e-05	0.00237	CbGpPWpGaD
Methadone—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—adrenal gland cancer	6.23e-05	0.00232	CbGpPWpGaD
Methadone—OPRM1—G alpha (i) signalling events—POMC—adrenal gland cancer	6.19e-05	0.0023	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—SDHB—adrenal gland cancer	6.11e-05	0.00227	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—GNRH1—adrenal gland cancer	6.06e-05	0.00226	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—SH3KBP1—adrenal gland cancer	5.97e-05	0.00222	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—SDHD—adrenal gland cancer	5.92e-05	0.0022	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—RRM1—adrenal gland cancer	5.92e-05	0.0022	CbGpPWpGaD
Methadone—OPRK1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	5.82e-05	0.00217	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—TSHR—adrenal gland cancer	5.81e-05	0.00216	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—ZNRF3—adrenal gland cancer	5.62e-05	0.00209	CbGpPWpGaD
Methadone—CYP1A2—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	5.6e-05	0.00208	CbGpPWpGaD
Methadone—OPRM1—GPCR ligand binding—GNAS—adrenal gland cancer	5.56e-05	0.00207	CbGpPWpGaD
Methadone—CYP19A1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	5.53e-05	0.00206	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—GNRH1—adrenal gland cancer	5.51e-05	0.00205	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—GNRHR—adrenal gland cancer	5.43e-05	0.00202	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—TSHR—adrenal gland cancer	5.4e-05	0.00201	CbGpPWpGaD
Methadone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	5.33e-05	0.00198	CbGpPWpGaD
Methadone—OPRD1—GPCR ligand binding—POMC—adrenal gland cancer	5.05e-05	0.00188	CbGpPWpGaD
Methadone—CYP2B6—Biological oxidations—POMC—adrenal gland cancer	5.05e-05	0.00188	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—SH3KBP1—adrenal gland cancer	5.05e-05	0.00188	CbGpPWpGaD
Methadone—CYP3A5—Biological oxidations—POMC—adrenal gland cancer	4.94e-05	0.00184	CbGpPWpGaD
Methadone—CYP19A1—Integrated Breast Cancer Pathway—EGFR—adrenal gland cancer	4.93e-05	0.00184	CbGpPWpGaD
Methadone—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	4.92e-05	0.00183	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—TSHR—adrenal gland cancer	4.91e-05	0.00183	CbGpPWpGaD
Methadone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	4.83e-05	0.0018	CbGpPWpGaD
Methadone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	4.83e-05	0.0018	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—PRKACA—adrenal gland cancer	4.75e-05	0.00177	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—ZNRF3—adrenal gland cancer	4.75e-05	0.00177	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—SDHD—adrenal gland cancer	4.53e-05	0.00169	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—RRM1—adrenal gland cancer	4.53e-05	0.00169	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—SDHB—adrenal gland cancer	4.52e-05	0.00168	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—CDC42—adrenal gland cancer	4.44e-05	0.00165	CbGpPWpGaD
Methadone—OPRK1—GPCR ligand binding—POMC—adrenal gland cancer	4.43e-05	0.00165	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—SDHB—adrenal gland cancer	4.41e-05	0.00164	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—MED12—adrenal gland cancer	4.41e-05	0.00164	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—GNRH1—adrenal gland cancer	4.39e-05	0.00163	CbGpPWpGaD
Methadone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	4.32e-05	0.00161	CbGpPWpGaD
Methadone—CYP2C8—Biological oxidations—POMC—adrenal gland cancer	4.28e-05	0.00159	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—GNAS—adrenal gland cancer	4.24e-05	0.00158	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—PRKACA—adrenal gland cancer	4.17e-05	0.00155	CbGpPWpGaD
Methadone—CYP19A1—Integrated Breast Cancer Pathway—TP53—adrenal gland cancer	4.14e-05	0.00154	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	4.12e-05	0.00153	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—CDC42—adrenal gland cancer	4.03e-05	0.0015	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—SPRY2—adrenal gland cancer	4.01e-05	0.00149	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—RRM1—adrenal gland cancer	3.93e-05	0.00146	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—SDHD—adrenal gland cancer	3.93e-05	0.00146	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—TSHR—adrenal gland cancer	3.91e-05	0.00146	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—CDC42—adrenal gland cancer	3.89e-05	0.00145	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—GNAS—adrenal gland cancer	3.85e-05	0.00143	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—GNRH1—adrenal gland cancer	3.85e-05	0.00143	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—SDHB—adrenal gland cancer	3.82e-05	0.00142	CbGpPWpGaD
Methadone—CYP2C19—Biological oxidations—POMC—adrenal gland cancer	3.82e-05	0.00142	CbGpPWpGaD
Methadone—OPRM1—GPCR ligand binding—POMC—adrenal gland cancer	3.75e-05	0.00139	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—GNAS—adrenal gland cancer	3.72e-05	0.00138	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	3.72e-05	0.00138	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	3.68e-05	0.00137	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—MEN1—adrenal gland cancer	3.68e-05	0.00137	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—CDC42—adrenal gland cancer	3.53e-05	0.00132	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—PRKACA—adrenal gland cancer	3.52e-05	0.00131	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—SPRY2—adrenal gland cancer	3.52e-05	0.00131	CbGpPWpGaD
Methadone—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	3.51e-05	0.00131	CbGpPWpGaD
Methadone—CYP2C9—Biological oxidations—POMC—adrenal gland cancer	3.48e-05	0.0013	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—TSHR—adrenal gland cancer	3.43e-05	0.00128	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—SDHB—adrenal gland cancer	3.41e-05	0.00127	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—MED12—adrenal gland cancer	3.38e-05	0.00126	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—GNAS—adrenal gland cancer	3.38e-05	0.00126	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	3.36e-05	0.00125	CbGpPWpGaD
Methadone—ABCB1—Metabolism—SDHB—adrenal gland cancer	3.33e-05	0.00124	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—CDC42—adrenal gland cancer	3.29e-05	0.00122	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—GNRH1—adrenal gland cancer	3.25e-05	0.00121	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—MEN1—adrenal gland cancer	3.23e-05	0.0012	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—PRKACA—adrenal gland cancer	3.22e-05	0.0012	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—GNAS—adrenal gland cancer	3.14e-05	0.00117	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—SDHB—adrenal gland cancer	3.14e-05	0.00117	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—SDHB—adrenal gland cancer	3.11e-05	0.00116	CbGpPWpGaD
Methadone—CYP19A1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	3.02e-05	0.00112	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	3.01e-05	0.00112	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—CDC42—adrenal gland cancer	2.99e-05	0.00111	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—SPRY2—adrenal gland cancer	2.97e-05	0.00111	CbGpPWpGaD
Methadone—CYP1A2—Biological oxidations—POMC—adrenal gland cancer	2.97e-05	0.00111	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—MED12—adrenal gland cancer	2.93e-05	0.00109	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—RRM1—adrenal gland cancer	2.91e-05	0.00108	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—SDHD—adrenal gland cancer	2.91e-05	0.00108	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—TSHR—adrenal gland cancer	2.9e-05	0.00108	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	2.87e-05	0.00107	CbGpPWpGaD
Methadone—OPRD1—GPCR downstream signaling—POMC—adrenal gland cancer	2.86e-05	0.00106	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—GNAS—adrenal gland cancer	2.85e-05	0.00106	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—SDHD—adrenal gland cancer	2.84e-05	0.00106	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—RRM1—adrenal gland cancer	2.84e-05	0.00106	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—PRKACA—adrenal gland cancer	2.81e-05	0.00104	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	2.73e-05	0.00102	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—MEN1—adrenal gland cancer	2.73e-05	0.00101	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	2.69e-05	0.000999	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—SDHB—adrenal gland cancer	2.66e-05	0.000989	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—GNAS—adrenal gland cancer	2.61e-05	0.000971	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—POMC—adrenal gland cancer	2.59e-05	0.000965	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—ABCB1—adrenal gland cancer	2.56e-05	0.000953	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—POMC—adrenal gland cancer	2.5e-05	0.000932	CbGpPWpGaD
Methadone—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	2.49e-05	0.000928	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—PRKACA—adrenal gland cancer	2.46e-05	0.000917	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—SDHD—adrenal gland cancer	2.46e-05	0.000917	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—RRM1—adrenal gland cancer	2.46e-05	0.000917	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—PRKACA—adrenal gland cancer	2.46e-05	0.000916	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	2.45e-05	0.000911	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	2.44e-05	0.00091	CbGpPWpGaD
Methadone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.41e-05	0.000896	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CDC42—adrenal gland cancer	2.38e-05	0.000886	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—IGF2—adrenal gland cancer	2.3e-05	0.000854	CbGpPWpGaD
Methadone—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	2.29e-05	0.000854	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—GNAS—adrenal gland cancer	2.28e-05	0.000847	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—POMC—adrenal gland cancer	2.27e-05	0.000846	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—IGF1R—adrenal gland cancer	2.22e-05	0.000826	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—RRM1—adrenal gland cancer	2.2e-05	0.000818	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—SDHD—adrenal gland cancer	2.2e-05	0.000818	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—MED12—adrenal gland cancer	2.17e-05	0.000807	CbGpPWpGaD
Methadone—ABCB1—Metabolism—RRM1—adrenal gland cancer	2.15e-05	0.000799	CbGpPWpGaD
Methadone—ABCB1—Metabolism—SDHD—adrenal gland cancer	2.15e-05	0.000799	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—PRKACA—adrenal gland cancer	2.14e-05	0.000796	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—MED12—adrenal gland cancer	2.12e-05	0.000789	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—POMC—adrenal gland cancer	2.12e-05	0.000788	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	2.09e-05	0.000779	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CDC42—adrenal gland cancer	2.09e-05	0.000777	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—PRKACA—adrenal gland cancer	2.08e-05	0.000774	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—SDHB—adrenal gland cancer	2.05e-05	0.000764	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—RRM1—adrenal gland cancer	2.02e-05	0.000753	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—SDHD—adrenal gland cancer	2.02e-05	0.000753	CbGpPWpGaD
Methadone—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	2.02e-05	0.000752	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—IGF2—adrenal gland cancer	2.01e-05	0.000749	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—RRM1—adrenal gland cancer	2e-05	0.000746	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—SDHD—adrenal gland cancer	2e-05	0.000746	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—GNAS—adrenal gland cancer	2e-05	0.000743	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—GNAS—adrenal gland cancer	2e-05	0.000743	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—ABCB1—adrenal gland cancer	1.96e-05	0.000729	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—IGF1R—adrenal gland cancer	1.95e-05	0.000724	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	1.94e-05	0.000721	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—POMC—adrenal gland cancer	1.92e-05	0.000715	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—TERT—adrenal gland cancer	1.91e-05	0.000711	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—MED12—adrenal gland cancer	1.84e-05	0.000684	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CDC42—adrenal gland cancer	1.76e-05	0.000657	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—POMC—adrenal gland cancer	1.76e-05	0.000654	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—GNAS—adrenal gland cancer	1.73e-05	0.000646	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—SDHD—adrenal gland cancer	1.71e-05	0.000638	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—RRM1—adrenal gland cancer	1.71e-05	0.000638	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—ABCB1—adrenal gland cancer	1.7e-05	0.000633	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—IGF2—adrenal gland cancer	1.7e-05	0.000633	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—GNAS—adrenal gland cancer	1.69e-05	0.000628	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—TERT—adrenal gland cancer	1.68e-05	0.000623	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—BAD—adrenal gland cancer	1.66e-05	0.000619	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—IGF1R—adrenal gland cancer	1.64e-05	0.000612	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.64e-05	0.000611	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—MED12—adrenal gland cancer	1.64e-05	0.00061	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	1.63e-05	0.000605	CbGpPWpGaD
Methadone—ABCB1—Metabolism—MED12—adrenal gland cancer	1.6e-05	0.000595	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PRKACA—adrenal gland cancer	1.58e-05	0.000589	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PRKACA—adrenal gland cancer	1.55e-05	0.000576	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—POMC—adrenal gland cancer	1.53e-05	0.00057	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—BRAF—adrenal gland cancer	1.51e-05	0.000563	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—MED12—adrenal gland cancer	1.51e-05	0.000561	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—MED12—adrenal gland cancer	1.49e-05	0.000556	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—EGFR—adrenal gland cancer	1.47e-05	0.000546	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.47e-05	0.000545	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—BAD—adrenal gland cancer	1.46e-05	0.000542	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—TERT—adrenal gland cancer	1.42e-05	0.000527	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—PTGS2—adrenal gland cancer	1.4e-05	0.000521	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—POMC—adrenal gland cancer	1.34e-05	0.000501	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—POMC—adrenal gland cancer	1.34e-05	0.0005	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PRKACA—adrenal gland cancer	1.34e-05	0.000499	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.34e-05	0.000497	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—BRAF—adrenal gland cancer	1.33e-05	0.000494	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—SDHD—adrenal gland cancer	1.32e-05	0.000492	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—RRM1—adrenal gland cancer	1.32e-05	0.000492	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.31e-05	0.000487	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—EGFR—adrenal gland cancer	1.29e-05	0.000479	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—GNAS—adrenal gland cancer	1.28e-05	0.000477	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—MED12—adrenal gland cancer	1.28e-05	0.000475	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—ABCB1—adrenal gland cancer	1.26e-05	0.000468	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—GNAS—adrenal gland cancer	1.25e-05	0.000467	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—BAD—adrenal gland cancer	1.23e-05	0.000458	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—ABCB1—adrenal gland cancer	1.23e-05	0.000458	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	1.2e-05	0.000445	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.17e-05	0.000435	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—POMC—adrenal gland cancer	1.17e-05	0.000435	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PRKACA—adrenal gland cancer	1.17e-05	0.000434	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.14e-05	0.000425	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—POMC—adrenal gland cancer	1.14e-05	0.000423	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—BRAF—adrenal gland cancer	1.12e-05	0.000417	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	1.1e-05	0.000409	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CTNNB1—adrenal gland cancer	1.09e-05	0.000407	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	1.09e-05	0.000406	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—EGFR—adrenal gland cancer	1.09e-05	0.000404	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—GNAS—adrenal gland cancer	1.09e-05	0.000404	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—PTGS2—adrenal gland cancer	1.07e-05	0.000399	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.07e-05	0.000397	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—ABCB1—adrenal gland cancer	1.07e-05	0.000397	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—MED12—adrenal gland cancer	9.86e-06	0.000367	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—GNAS—adrenal gland cancer	9.69e-06	0.000361	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CTNNB1—adrenal gland cancer	9.59e-06	0.000357	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	9.51e-06	0.000354	CbGpPWpGaD
Methadone—ABCB1—Metabolism—GNAS—adrenal gland cancer	9.46e-06	0.000352	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PRKACA—adrenal gland cancer	9.32e-06	0.000347	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—PTGS2—adrenal gland cancer	9.31e-06	0.000347	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	9.11e-06	0.000339	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—GNAS—adrenal gland cancer	8.92e-06	0.000332	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—GNAS—adrenal gland cancer	8.84e-06	0.000329	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	8.75e-06	0.000326	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	8.67e-06	0.000323	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—EGFR—adrenal gland cancer	8.66e-06	0.000322	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—POMC—adrenal gland cancer	8.64e-06	0.000321	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—POMC—adrenal gland cancer	8.44e-06	0.000314	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CTNNB1—adrenal gland cancer	8.1e-06	0.000302	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—EGFR—adrenal gland cancer	7.6e-06	0.000283	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—GNAS—adrenal gland cancer	7.55e-06	0.000281	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—ABCB1—adrenal gland cancer	7.41e-06	0.000276	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—POMC—adrenal gland cancer	7.31e-06	0.000272	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—TP53—adrenal gland cancer	7.27e-06	0.000271	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	7.19e-06	0.000268	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PTGS2—adrenal gland cancer	6.89e-06	0.000256	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PTGS2—adrenal gland cancer	6.73e-06	0.000251	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—POMC—adrenal gland cancer	6.53e-06	0.000243	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—EGFR—adrenal gland cancer	6.42e-06	0.000239	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—TP53—adrenal gland cancer	6.38e-06	0.000237	CbGpPWpGaD
Methadone—ABCB1—Metabolism—POMC—adrenal gland cancer	6.37e-06	0.000237	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—POMC—adrenal gland cancer	6e-06	0.000223	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—POMC—adrenal gland cancer	5.95e-06	0.000221	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PTGS2—adrenal gland cancer	5.83e-06	0.000217	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GNAS—adrenal gland cancer	5.83e-06	0.000217	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	5.72e-06	0.000213	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—TP53—adrenal gland cancer	5.39e-06	0.000201	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	5.21e-06	0.000194	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—POMC—adrenal gland cancer	5.09e-06	0.000189	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PTGS2—adrenal gland cancer	5.08e-06	0.000189	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	4.79e-06	0.000178	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	4.75e-06	0.000177	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PTGS2—adrenal gland cancer	4.06e-06	0.000151	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—POMC—adrenal gland cancer	3.92e-06	0.000146	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	3.13e-06	0.000117	CbGpPWpGaD
